logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

The central parity rate of the RMB against the US dollar is reported at 6.7904, lowering by 9 points from the previous day.

date
07/08/2026
The central parity rate of the renminbi against the US dollar is reported at 6.7904, which is a decrease of 9 points from the previous day.
Latest
2 m ago
The concept of innovative drugs continues to rise, with companies like Hasun Pharmaceutical and Baihua Medicine reaching limit up.
3 m ago
Challenging Apple! OpenAI's first AI hardware unveiled: the smart speaker market welcomes an "AI-native" disruptor.
3 m ago
The rare earth permanent magnet sector surged sharply, and Chinese rare earths hit the daily limit.
4 m ago
Zijin Mining's latest response: The relevant copper mines it owns do not fall under the products prohibited for export by Congo.
6 m ago
Hong Kong Stock Movement | WuXi Biologics (02269.HK) rises over 4%, plans to acquire Chengsheng Pharmaceuticals process development and production base in Hangzhou.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.